Y-Intercept (HK)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.6M Buy
110,892
+105,744
+2,054% +$9.32M 0.21% 87
2026
Q2
$403K Sell
5,148
-73,840
-93% -$5.96M 0.01% 1371
2026
Q1
$6.84M Sell
78,988
-55,393
-41% -$5.31M 0.13% 223
2025
Q4
$12.9M Buy
134,381
+132,074
+5,725% +$12.8M 0.29% 45
2025
Q3
$220K Buy
+2,307
New +$212K 0.01% 1456
2025
Q2
– Sell
-26,053
Closed -$2.34M – 1861
2025
Q1
$2.34M Buy
+26,053
New +$2.33M 0.16% 153
2024
Q4
– Sell
-73,593
Closed -$6.63M – 1469
2024
Q3
$6.63M Buy
73,593
+56,178
+323% +$4.73M 0.41% 26
2024
Q2
$1.37M Sell
17,415
-22,330
-56% -$1.83M 0.08% 367
2024
Q1
$3.46M Buy
39,745
+34,380
+641% +$2.93M 0.26% 74
2023
Q4
$442K Buy
+5,365
New +$409K 0.04% 654
2023
Q3
– Sell
-6,111
Closed -$538K – 1386
2023
Q2
$538K Buy
6,111
+3,472
+132% +$299K 0.06% 538
2023
Q1
$213K Sell
2,639
-5,914
-69% -$482K 0.02% 937
2022
Q4
$665K Sell
8,553
-7,474
-47% -$606K 0.1% 329
2022
Q3
$1.29M Buy
16,027
+11,641
+265% +$1.05M 0.13% 236
2022
Q2
$394K Sell
4,386
-11,908
-73% -$1.21M 0.05% 492
2022
Q1
$1.81M Buy
16,294
+2,460
+18% +$260K 0.41% 40
2021
Q4
$1.43M Buy
+13,834
New +$1.6M 0.34% 60
2021
Q3
– Sell
-6,853
Closed -$851K – 807
2021
Q2
$851K Buy
6,853
+145
+2% +$18.2K 0.22% 128
2021
Q1
$797K Buy
6,708
+3,894
+138% +$456K 0.21% 140
2020
Q4
$325K Buy
+2,814
New +$310K 0.14% 285

Other funds holding MDT

Y-Intercept (HK)'s MDT Position: Q3 2026 in Review

Y-Intercept (HK) increased its Medtronic (MDT) stake by 2,054% in Q3 2026, buying an estimated $9.32M and bringing the position to 110,892 shares worth $9.6M. The position accounts for 0.21% of the portfolio, ranked #87.

Y-Intercept (HK) first reported a position in MDT in Q4 2020 and has held it in 20 quarters since. The position peaked at $12.9M in Q4 2025. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Y-Intercept (HK) held 110,892 shares of Medtronic worth $9.6M as of Q3 2026.
  • Y-Intercept (HK) bought 105,744 Medtronic shares in Q3 2026, an estimated $9.32M.
  • Medtronic made up 0.21% of Y-Intercept (HK)'s portfolio in Q3 2026, its #87 holding.
  • Y-Intercept (HK) first reported a position in Medtronic in Q4 2020 and has held it in 20 quarters since.
  • Y-Intercept (HK)'s Medtronic position peaked at $12.9M in Q4 2025.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.